RefDoc
Haut

Faire une nouvelle recherche
Make a new search
Lancer la recherche


Titre du document / Document title

Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance

Auteur(s) / Author(s)

PHAM Tan (1) ; CORNEA Anna (1) ; BLICK Kenneth E. (2) ; JENKINS Alicia (1) ; HAL SCOFIELD R. (1 3) ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

(1) Department of Endocrinology Metabolism, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, ETATS-UNIS
(2) Diabetes Division, Departments of Medicine and Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, ETATS-UNIS
(3) Medical Service, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, ETATS-UNIS
(4) Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, ETATS-UNIS

Résumé / Abstract

Background:Glucosamine is used to treat osteoarthritis. In animals, the compound is known to cause insulin resistance, the underlying abnormality in type 2 diabetes mellitus. Insulin resistance in humans taking oral glucosamine in doses used for osteoarthritis has not been studied. Methods: Volunteer human subjects (n = 38) without known abnormality of glucose homeostasis had fasting serum glucose, insulin, and lipids determined before and after taking 1500 mg glucosamine by mouth every day for 6 weeks. Fasting insulin and glucose were used to calculate homeostasis model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI). Vascular elasticity was measured by pulse wave analysis. The paired Student's test was used to compare baseline with posttreatment values. Pearson's correlation was used to determine the relation of baseline HOMA-IR with changes in other variables. Results: We found a rise in HOMA-IR after 6 weeks of glucosamine (2.8 versus 3.2, P < 0.04). The fall in HOMA-IR among the subjects was statistically related to a higher baseline HOMA-IR by Pearson's correlation (P < 0.01). A rise in serum triglycerides and a rise in LDL cholesterol were statistically related to baseline HOMA-IR. Small artery elasticity fell, and the decrease was higher in those with the highest baseline HOMA-IR. Conclusions: Notwithstanding its efficacy remaining in question, glucosamine is widely used as treatment for osteoarthritis, which is a condition associated with both obesity and type 2 diabetes mellitus. Our data indicate that persons with underlying poorer insulin sensitivity are at risk for worsening insulin resistance and vascular function with the use of glucosamine in doses used to treat osteoarthritis.

Revue / Journal Title

The American journal of the medical sciences    ISSN  0002-9629   CODEN AJMSA9 

Source / Source

2007, vol. 333, no6, pp. 333-339 [7 page(s) (article)] (53 ref.)

Langue / Language

Anglais

Editeur / Publisher

Lippincott Williams & Wilkins, Hagerstown, MD, ETATS-UNIS  (1827) (Revue)

Mots-clés anglais / English Keywords

Nutrition disorder

;

Endocrinopathy

;

Diseases of the osteoarticular system

;

Degenerative disease

;

Arthropathy

;

Nutritional status

;

Antirheumatic agent

;

Medicine

;

Human

;

Target tissue resistance

;

Insulin

;

Treatment

;

Obesity

;

Use

;

Dose

;

Insulin resistance

;

Glucosamine

;

Oral administration

;

Osteoarthritis

;

Mots-clés français / French Keywords

Trouble nutrition

;

Endocrinopathie

;

Système ostéoarticulaire pathologie

;

Maladie dégénérative

;

Arthropathie

;

Etat nutritionnel

;

Antirhumatismal

;

Médecine

;

Homme

;

Résistance tissu cible

;

Insuline

;

Traitement

;

Obésité

;

Utilisation

;

Dose

;

Insulinoresistance

;

Glucosamine

;

Voie orale

;

Arthrose

;

Mots-clés espagnols / Spanish Keywords

Trastorno nutricíon

;

Endocrinopatía

;

Sistema osteoarticular patología

;

Enfermedad degenerativa

;

Artropatía

;

Estado nutricional

;

Antireumático

;

Medicina

;

Hombre

;

Resistencia tejido blanco

;

Insulina

;

Tratamiento

;

Obesidad

;

Uso

;

Dosis

;

Resistancia insulina

;

Glucosamina

;

Vía oral

;

Artrosis

;

Mots-clés d'auteur / Author Keywords

Glucosamine

;

Insulin sensitivity

;

Obesity

;

Human

;

Localisation / Location

INIST-CNRS, Cote INIST : 2054, 35400014942297.0030

Nº notice refdoc (ud4) : 18850195



Faire une nouvelle recherche
Make a new search
Lancer la recherche
Bas